Contact Us   |   Print Page   |   Sign In   |   Join
News and Press: Member Organization News

Tetra Discovery Partners Secures $4.28 Million in VC Funding for New Drug

Friday, August 5, 2016   (0 Comments)
Posted by: Kate Oesterle
Share |

GRAND RAPIDS — In raising an additional $4.28 million in venture capital funding, Tetra Discovery Partners LLC plans to support the ongoing clinical trials for a new drug to treat Alzheimer’s disease.

The Grand Rapids- and Kalamazoo-based Tetra Discovery Partners netted the funding as part of a $7.27 million Series A venture round that CEO Mark Gurney expects will successfully conclude within the next three months.

“We’re confident we’ll complete this round,” Gurney said.

Tetra Discovery Partners recently provided an update on the fundraising round and equity offering through a filing to the U.S. Securities and Exchange Commission. The amount raised so far came from nine investors, according to the filing. Lead investors include Apjohn Ventures LLC in Kalamazoo and Holland-based Grand Angels, Gurney said.

Read full article.

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal